1.Occupational Hepatic Disorders in Korea.
Hyoung Ryoul KIM ; Tae Woo KIM
Journal of Korean Medical Science 2010;25(Suppl):S36-S40
Occupational hepatic disorders are classified into toxic hepatitis, viral hepatitis, and chemical-induced malignancy in Korea. Toxic hepatitis cases were reported in workers who were exposed to dimethylformamide, dimethylacetamide, or trichloroethylene. Pre-placement medical examination and regular follow-up are necessary to prevent the development of toxic hepatitis. Viral hepatitis was chiefly reported among health care workers such as doctors, nurses and clinical pathology technicians who could easily be exposed to blood. Preventive measures for these groups therefore include vaccination and serum monitoring programs. Hepatic angiosarcoma caused by vinyl chloride monomer (VCM) exposure is a very well known occupational disease and it has not been officially reported in Korea yet. Some cases of hepatocellular carcinoma were legally approved for compensation as an occupational disease largely by overwork and stress, but not supported by enough scientific evidence. Effort to find the evidence of its causal relationship is needed.
Adult
;
Drug-Induced Liver Injury/epidemiology
;
Female
;
Health Personnel
;
Hepatitis, Viral, Human/epidemiology/prevention & control
;
Humans
;
Liver Diseases/*epidemiology/prevention & control
;
Liver Neoplasms/chemically induced/epidemiology
;
Male
;
Middle Aged
;
Occupational Diseases/*chemically induced/*epidemiology/prevention & control
;
Occupational Exposure/adverse effects
;
Republic of Korea/epidemiology
;
Young Adult
2.Emerging Need for Vaccination against Hepatitis A Virus in Patients with Chronic Liver Disease in Korea.
Hyun Joo SONG ; Tae Hun KIM ; Ji Hyun SONG ; Hee Jung OH ; Kum Hei RYU ; Hye Jung YEOM ; Seong Eun KIM ; Hye Kyung JUNG ; Ki Nam SHIM ; Sung Ae JUNG ; Kwon YOO ; Il Hwan MOON ; Kyu Won CHUNG
Journal of Korean Medical Science 2007;22(2):218-222
Vaccination against hepatitis A virus (HAV) is recommended for patients with chronic liver disease (CLD), but this has been deemed unnecessary in Korea since the immunity against HAV was almost universal in adults. However, this practice has never been reevaluated with respect to the changing incidence of adult acute hepatitis A. We retrospectively reviewed the medical records of 278 patients with acute hepatitis A diagnosed from January 1995 to November 2005 and prospectively tested 419 consecutive CLD patients from July to December 2005 for the presence of IgG anti-HAV. The number of patients with acute hepatitis A has markedly increased recently, and the proportion of adult patients older than 30 yr has been growing from 15.2% during 1995-1999, to 28.4% during 2000-2005 (p=0.019). Among 419 CLD patients, the seroprevalences of IgG anti-HAV were 23.1% for those between 26 and 30 yr, 64% between 31 and 35 yr, and 85.0% between 36 and 40 yr. These data demonstrate that immunity against HAV is no more universal in adult and substantial proportion of adult CLD patients are now at risk of HAV infection in Korea. Therefore, further study on seeking proper strategy of active immunization against HAV is warranted in these populations.
Risk Factors
;
Risk Assessment/methods
;
Middle Aged
;
Male
;
Liver Diseases/*epidemiology/*prevention & control
;
Korea/epidemiology
;
Infant, Newborn
;
Infant
;
Incidence
;
Humans
;
Hepatitis A Vaccines/*therapeutic use
;
Hepatitis A/*epidemiology/*prevention & control
;
Female
;
Disease Outbreaks/*prevention & control/*statistics & numerical data
;
Comorbidity
;
Communicable Diseases, Emerging/epidemiology/prevention & control
;
Chronic Disease
;
Child, Preschool
;
Child
;
Aged, 80 and over
;
Aged
;
Adult
;
Adolescent
3.Hepatitis B and C Virus Infection and Liver Dysfunction in Patients Receiving Chemotherapy.
Chang Il KWON ; Ji Hyun LEE ; Ki Hyun CHOI ; Kwang Hyun KO ; Sung Pyo HONG ; Seong Gyu HWANG ; Pil Won PARK ; Doyeun OH ; Kyu Sung RIM ; Sehyun KIM
The Korean Journal of Gastroenterology 2006;48(6):408-414
BACKGROUND/AIMS: Liver dysfunction and reactivation of hepatitis virus are well-described complications in cancer patients who receive cytotoxic chemotherapy and may result in varying degrees of liver damage. However, there has been just few reports on such complications and on the preemptive use of lamivudine in Korea. The aims of this study were to determine the prevalence of hepatitis B and C virus infection and the incidence of liver dysfunction in patients with malignancies who receive chemotherapy, to determine the reactivation rate of hepatitis B virus (HBV) in those patients, to evaluate the effect of preemptive use of lamivudine in patients with HBV infection. METHODS: Among 1,477 patients who received chemotherapy due to various malignancies from January 2000 to June 2005, 668 patients with incomplete viral studies or hepatitis related malignancy were excluded. A retrospective study was conducted by reviewing the medical records of remaining 809 patients. RESULTS: The overall prevalence rate of hepatitis B or C virus in patients receiving chemotherapy was 6.55% (53/809). The incidences of liver dysfunction was not significantly different between hepatitis virus positive group and negative group. Reactivation rate of hepatiris B or C virus after chemotherapy was 15% (6/40). In all patients who received lamivudine therapy, aspartate aminotransferase and alanine aminotransferase level were normalized and HBV DNA negativity achieved. CONCLUSIONS: The existence of hepatitis virus in patients receiving chemotherapy did not significantly influence the development of severe liver dysfunction, owing probably to the lamivudine therapy. Further prospective studies are required to ascertain the reactivation of hepatitis virus in patients receiving chemotherapy and the need for prophylactic lamivudine therapy in HBV positive patients.
Adult
;
Antineoplastic Agents/*adverse effects
;
Antiviral Agents/*therapeutic use
;
Female
;
Hepatitis B/diagnosis/epidemiology/*prevention & control
;
Hepatitis C/diagnosis/epidemiology/*prevention & control
;
Humans
;
Lamivudine/*therapeutic use
;
Liver Diseases/chemically induced/*diagnosis/epidemiology
;
Male
;
Middle Aged
;
Neoplasms/complications/drug therapy
;
Prevalence
4.Clinical Effects of Bile Aspiration Just before Contrast Injection during Endoscopic Retrograde Cholangiopancreatography.
Jung Sik CHOI ; Dae Hwan KANG ; Hyun Dae KIM ; Sang Hwa URM ; Sang Heun LEE ; Ji Hyun KIM ; Sam Ryong JEE ; Eun Uk JUNG ; Sung Jae PARK ; Youn Jae LEE ; Sang Young SEOL
The Korean Journal of Gastroenterology 2012;60(6):368-372
BACKGROUND/AIMS: This study was designed to determine whether bile aspiration before contrast injection cholangiogram prevent of post-ERCP cholangitis, liver function worsening, cholecystitis and pancreatitis. METHODS: One hundred and two patients in the bile aspiration group before contrast injection from December 1, 2008 to December 30, 2009 and 115 patients in the conventional control group from January 1, 2010 to June 30, 2010 were analyzed. The incidence of post-ERCP cholangitis, liver function worsening, cholecystitis, pancreatitis, and hyperamylasemia only were compared between these two groups. RESULTS: In the 102 patients with the bile aspiration group, post-ERCP cholangitis in 3 patients (2.9%), liver function worsening in 4 patients (3.9%), cholecystitis and pancreatitis in none, and hyperamylasemia only in 6 patients (5.8%) occurred. In the 115 patients with control group, post-ERCP cholangitis in 1 patient (0.4%), liver function worsening in 9 patients (7.8%), cholecystitis in none, pancreatitis in 3 patients (2.6%), hyperamylasemia only in 10 patients (8.6%) developed. The two groups did not significantly differ in terms of the incidence of post-ERCP cholangitis, liver function worsening, pancreatitis, and hyperamylasemia only (p>0.05). CONCLUSIONS: Initially bile juice aspiration just before contrast injection into the bile duct rarely prevented post-ERCP cholangitis, liver function worsening, and pancreatitis in patients with the extrahepatic bile duct obstruction.
Adult
;
Aged
;
Aged, 80 and over
;
*Bile
;
Cholangiopancreatography, Endoscopic Retrograde/*adverse effects
;
Cholangitis/epidemiology/etiology/prevention & control
;
Contrast Media/*diagnostic use
;
Female
;
Humans
;
Hyperamylasemia/epidemiology/etiology/prevention & control
;
Incidence
;
Liver Diseases/physiopathology
;
Liver Function Tests
;
Male
;
Middle Aged
;
Pancreatitis/epidemiology/etiology/prevention & control
;
Suction
5.Therapeutical effect of combined hepatic resection and fenestration on patients with severe adult polycystic liver disease.
Wei CHEN ; Hai-Bin ZHANG ; Yong FU ; Hui SIMA ; Ning YANG ; Guang-Shun YANG
Chinese Journal of Hepatology 2010;18(1):41-44
OBJECTIVETo evaluate therapeutical effect of combined hepatic resection and fenestration on patients with severe adult polycystic liver disease (APLD).
METHODSPreoperative clinical symptoms, postoperative complications and prognoses from 33 patients with severe adult polycystic liver disease (APLD) treated with combined hepatic resection and fenestration were recorded. According to the number and location of cysts before surgery and the remnant liver parenchyma after operation, all patients were classified into two types: class A and B. And patients in each type were further classified into three grades: Grade I, II and III. The frequency of postoperative complications of two types patients was compared.
RESULTSThe mean follow-up time was 57 months. There were three patients with recurrence of symptoms at 81, 68 and 43 mouths after operation. Two patients died of renal failure due to polycystic kidney disease at 137 and 85 mouths after operation. And one patient with postoperative hepatic inadequacy received an orthotopic liver transplantation. The total number of patients with postoperative complications was 26 cases, including one patient with bleeding, two patients with bile leakage, fourteen patients with mild ascites, twelve patients with severe ascites and eighteen patients with pleural effusion, and the overall incidence was 78.8%. There were 22 patients with imaging data, including 6 patients within A type and sixteen patients within B type. The frequencies of postoperative complications were 4 and 31, respectively, and the difference was statistically significant (Chi-square test = 4.99, P less than 0.05).
CONCLUSIONCombined hepatic resection and fenestration is a safe and acceptable procedure for the treatment of severe APLD.
Adult ; Aged ; Ascites ; epidemiology ; etiology ; Cysts ; diagnostic imaging ; pathology ; surgery ; Female ; Follow-Up Studies ; Hepatectomy ; methods ; Humans ; Liver ; diagnostic imaging ; pathology ; surgery ; Liver Diseases ; diagnostic imaging ; pathology ; surgery ; Male ; Middle Aged ; Pleural Effusion ; epidemiology ; etiology ; Postoperative Complications ; epidemiology ; prevention & control ; Prognosis ; Recurrence ; Retrospective Studies ; Severity of Illness Index ; Tomography, X-Ray Computed ; Treatment Outcome